Chinese companies have an edge in developing drugs with the help of AI, thanks to the country's advanced hardware, talent pool, and robust supply chain, according to Wen Shuhao, co-founder and chairman of XtalPi. He noted that this made China a favorable option for international businesses expanding in this field.